Remove Marketing Remove Operations Remove Pharmaceuticals
article thumbnail

Combatting COVID-19 in Emerging Markets

Tom Spencer

These non-pharmaceutical interventions ( NPI’s ) presented challenges for many workers especially in manufacturing and production industries. Much less emphasis has been placed on developing tools suitable for emerging markets and the businesses in these economies. Obstacles in Emerging Markets. Contact Tracing Apps.

Marketing 103
article thumbnail

Lobbyists Are Behind the Rise in Corporate Profits

Harvard Business

Operating margins for firms publicly listed in the US show a substantial and sustained rise. Firms engage in political “rent seeking”—lobbying for regulations that provide them sheltered markets—rather than competing on innovation. Profits are up. Corporate valuations are up as well.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

2024 Events for Project Managers, Business Leaders, and Industry Professionals

Epicflow

The attendees of the event will have a chance to explore the recent trends and changes in applying conversational AI within the European market. The conference will cover a range of topics – emerging technologies, diversity, soft skills development, inspiration for project managers, and more.

Industry 130
article thumbnail

How Chinese Companies Disrupt Through Business Model Innovation

Harvard Business

The difference between displacement (outperforming existing market incumbents at their own game) and disruption (changing the game) is strategically important, no matter how similar the pain they cause is. Drucker Forum 2016: The Entrepreneurial Society. Displacement generally is easier to combat than disruption.

Company 125
article thumbnail

What Could Amazon’s Approach to Health Care Look Like?

Harvard Business

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families. .”

Retail 134
article thumbnail

The 5 Elements of a Strong Leadership Pipeline

Harvard Business

Barbara Kellerman from Harvard, Jeffrey Pfeffer from Stanford, and numerous other experts have pointed out that the development market is filled with fads — slick behavioral models and fun, engaging tools — that don’t really move the needle. But there’s little evidence that much of this works. Insight Center.

article thumbnail

Research: Business School Really Does Influence How Students Make Decisions Later On

Harvard Business

As chief executive from 1972 to 1994, Richard Gelb (HBS, 1950) orchestrated Bristol-Myers’ acquisition of Squibb and transformed the firm from a personal care company to a diversified pharmaceutical giant. ” The thinking on diversification later changed, turning into skepticism in the 1970s and outright criticism in the 1980s.

Research 132